{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T23:10:02Z","timestamp":1735686602640,"version":"3.32.0"},"reference-count":25,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"published-print":{"date-parts":[[1999,12]]},"abstract":"<jats:p>Nas \u00faltimas duas d\u00e9cadas, os estudos com ant\u00edgenos que possam conferir imunidade protetora \u00e0 infec\u00e7\u00e3o experimental pelo Schistosoma mansoni tiveram grande impulso, especialmente devido ao avan\u00e7o dos conhecimentos nos campos da biologia molecular e da imunologia. Embora, estes estudos tenham trazidos novas e importantes contribui\u00e7\u00f5es, at\u00e9 o momento, a prote\u00e7\u00e3o conferida tem girado em torno de 50% de diminui\u00e7\u00e3o do n\u00famero de vermes e com alguns ant\u00edgenos, tamb\u00e9m do n\u00famero de ovos. As muitas perguntas ainda n\u00e3o respondidas indicam a necessidade de novas pesquisas a serem realizadas em animais de pequeno e grande porte, antes que estes ant\u00edgenos candidatos a vacina, possam ser utlizados em ensaios cl\u00ednicos.<\/jats:p>","DOI":"10.1590\/s0037-86821999000600014","type":"journal-article","created":{"date-parts":[[2005,4,26]],"date-time":"2005-04-26T16:46:21Z","timestamp":1114533981000},"page":"705-711","source":"Crossref","is-referenced-by-count":2,"title":["Dificuldades no desenvolvimento de uma vacina para a esquistossomose mansoni"],"prefix":"10.1590","volume":"32","author":[{"given":"Naftale","family":"Katz","sequence":"first","affiliation":[{"name":"Centro de Pesquisas Ren\u00e9 Rachou, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"890","DOI":"10.4269\/ajtmh.1980.29.890","article-title":"Susceptibility to chemotherapeutic agents of strains of Schistosoma mansoni isolated from treated and untreated patients","volume":"29","author":"Ara\u00fajo N","year":"1980","journal-title":"American Journal of Tropical Medicine and Hygiene","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0035-9203(93)90098-B","article-title":"Antischistosomal vaccines: beyond the laboratory","volume":"87","author":"Basch PF","year":"1993","journal-title":"Transactions of the Royal Society Tropical Medicine and Hygiene"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0169-4758(97)01207-6","article-title":"Schistosomiasis vaccines: Research to development","volume":"14","author":"Bergquist NR","year":"1998","journal-title":"Parasitology Today","ISSN":"https:\/\/id.crossref.org\/issn\/0169-4707","issn-type":"print"},{"year":"1977","series-title":"Influ\u00eancia da terap\u00eautica espec\u00edfica na evolu\u00e7\u00e3o da esquistossomose mansoni","author":"Bina JC","key":"ref4"},{"key":"ref5","first-page":"339","article-title":"Vaccination of goats against the trematode Schistosoma bovis with a recombinante homologous schistosome-derived glutathione S-transferase","volume":"16","author":"Boulanger D","year":"1994","journal-title":"Parasite Imunology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-3024.1995.tb00903.x","article-title":"Vaccination of patas mokeys experimentally infected with Schistosoma haematobium using a recombinant gluthathione S-transferase cloned from S. mansoni","volume":"17","author":"Boulanger D","year":"1995","journal-title":"Parasite Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0141-9838","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1590\/S0034-89101978000100013","article-title":"Linhagem humana de Schistosoma mansoni resistente a esquistossomicidas","volume":"12","author":"Dias LCS","year":"1978","journal-title":"Revista de Sa\u00fade P\u00fablica de S\u00e3o Paulo"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0169-4758(97)01207-6","article-title":"Schistosomiasis Vaccines: Research to Development","volume":"14","author":"Gryssels B","year":"1998","journal-title":"Parasitology Today","ISSN":"https:\/\/id.crossref.org\/issn\/0169-4707","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0001-706X(95)91938-5","article-title":"Desirable characteristics of a schistosomiasis vaccine: some implications of a cost-effectiveness analysis","volume":"59","author":"Guyatt HL","year":"1995","journal-title":"Acta Tropica","ISSN":"https:\/\/id.crossref.org\/issn\/0001-706X","issn-type":"print"},{"key":"ref10","first-page":"40","article-title":"Experi\u00eancias com quimioterapia em grande escala no controle da esquistossomose no Brasil","volume":"22","author":"Katz N","year":"1980","journal-title":"Revista do Instituto de Medicina Tropical de S\u00e3o Paulo","ISSN":"https:\/\/id.crossref.org\/issn\/0036-4665","issn-type":"print"},{"key":"ref11","first-page":"34","article-title":"Vacina polivalente anti-helmintos?","volume":"1","author":"Katz N","year":"1997","journal-title":"Biotecnologia Ci\u00eancia & Desenvolvimento Ano"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-4758(99)01421-0","article-title":"Schistosomiasis vaccines: The need for more research before clinical trials","volume":"15","author":"Katz N","year":"1999","journal-title":"Parasitology Today","ISSN":"https:\/\/id.crossref.org\/issn\/0169-4707","issn-type":"print"},{"key":"ref13","first-page":"273","article-title":"Re-Infection of patients in schistosomiasis mansoni endemic areas after specific treatment","volume":"20","author":"Katz N","year":"1978","journal-title":"Revista do Instituto de Medicina Tropical de S\u00e3o Paulo","ISSN":"https:\/\/id.crossref.org\/issn\/0036-4665","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1590\/S0074-02761995000200016","article-title":"Opportunitites and constraints in schistosomiasis vaccine development: Infection characteristics and industry realities","volume":"90","author":"Mitchell GF","year":"1995","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz","ISSN":"https:\/\/id.crossref.org\/issn\/0074-0276","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1073\/pnas.85.15.5678","article-title":"Induction of potective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen","volume":"85","author":"Pearce EJ","year":"1988","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4049\/jimmunol.152.1.193","article-title":"T and B epitope determination and analysis of multiple antigenic peptides for the S. mansoni experimental vaccine triose-phosphate isomerase","volume":"152","author":"Reynolds SR","year":"1994","journal-title":"Journal of Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1128\/IAI.60.1.90-94.1992","article-title":"Comparison of irradiated-cercaria schistosome vaccine models that use 15- and 50-Kilorad doses: the 15-Kilorad dose gives greater protection, smaller liver sizes, and higher gamma interferon levels after challenge","volume":"60","author":"Reynolds SR","year":"1992","journal-title":"Infection and Immunity","ISSN":"https:\/\/id.crossref.org\/issn\/0019-9567","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.4049\/jimmunol.149.12.3995","article-title":"T and B cell epitope mapping of Sm23, an integral membrane protein S. mansoni","volume":"149","author":"Reynolds SR","year":"1992","journal-title":"Journal of Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1128\/IAI.61.1.146-154.1993","article-title":"Candidate vaccine antigens identified by antibodies from mice vaccinated with 15 - or - 50-Kilorad-iradiated cercariae of Schistosoma mansoni","volume":"61","author":"Richter D","year":"1993","journal-title":"Infection and Immunity","ISSN":"https:\/\/id.crossref.org\/issn\/0019-9567","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0014-4894(92)90202-L","article-title":"Fasciola hepatica: molecular cloning, nucleotide sequence, and expression of a gene encoding a polypeptide homologous to a Schistosoma mansoni fatty acid-binding protein","volume":"74","author":"Rodriguez-P\u00e9rez J","year":"1992","journal-title":"Experimental Parasitology","ISSN":"https:\/\/id.crossref.org\/issn\/0014-4894","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.4049\/jimmunol.149.11.3612","article-title":"Induction of protective immunity in mice using a 62-kDa recombinant fragment of a Schistosoma mansoni surface antigen","volume":"149","author":"Soisson LMA","year":"1992","journal-title":"Journal of Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1073\/pnas.93.1.269","article-title":"A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine","volume":"93","author":"Tendler M","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0264-410X(95)00083-D","article-title":"Human schistosomiasis: potential consequences of vaccination","volume":"13","author":"Woolhouse MEJ","year":"1995","journal-title":"Vaccine","ISSN":"https:\/\/id.crossref.org\/issn\/0264-410X","issn-type":"print"},{"year":"1996","series-title":"WHO Fact Sheet on Schistosomiasis","key":"ref24"},{"year":"1999","series-title":"Workplan of the Steering Committee on Vaccine Discovery Research (VDR)","key":"ref25"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rsbmt\/v32n6\/0869.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T22:31:42Z","timestamp":1735684302000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86821999000600014&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["S0037-86821999000600014"],"URL":"https:\/\/doi.org\/10.1590\/s0037-86821999000600014","relation":{},"ISSN":["0037-8682"],"issn-type":[{"type":"electronic","value":"0037-8682"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}